Literature DB >> 25976621

Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?

Paolo Carta1, Lorenzo Di Maria2, Leonardo Caroti2, Elisa Buti2, Giulia Antognoli2, Enrico Eugenio Minetti2.   

Abstract

The role of anti-human leukocyte antigens DQ region (HLA-DQ) in transplantation is historically less studied than HLA-DR and HLA class I regions, but several studies are demonstrating that anti HLA-DQ antibodies are among the most frequent anti HLA antibodies that develop after transplantation and can have great influence on the developing of humoral rejection and graft loss. In this article we review the gene structure and nomenclature of the HLA-DQ region, the role of anti HLA-DQ antibodies after and before transplantation and briefly the associations of particular HLA-DQ alleles and other diseases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25976621     DOI: 10.1016/j.trre.2015.04.003

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN: 0955-470X            Impact factor:   3.943


  3 in total

1.  Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.

Authors:  Hyeyoung Lee; Ji Won Min; Ji-Il Kim; In-Sung Moon; Ki-Hyun Park; Chul Woo Yang; Byung Ha Chung; Eun-Jee Oh
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

2.  Two Cases of Antibody-Mediated Rejection Following Kidney Transplantation due to HLA-DQB1 Allele-Specific and DQ Alpha Protein-Specific HLA Antibodies.

Authors:  Seung Hwan Song; Borae G Park; Beom Seok Kim; Yu Seun Kim; Hyon Suk Kim
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

Review 3.  Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.

Authors:  Tilahun Alelign; Momina M Ahmed; Kidist Bobosha; Yewondwossen Tadesse; Rawleigh Howe; Beyene Petros
Journal:  J Immunol Res       Date:  2018-03-05       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.